Stuttgart - Delayed Quote EUR

Roche Holding AG (RHO6.SG)

33.94

-0.60

(-1.73%)

At close: May 9 at 4:32:34 PM GMT+2

Key Events

Loading Chart for RHO6.SG

Previous Close 34.53
Open 34.64
Bid 33.66 x 878200
Ask 34.35 x 863700
Day's Range 33.94 - 34.64
52 Week Range 27.73 - 40.38
Volume 0
Avg. Volume 12
Market Cap (intraday) --
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) --
Earnings Date Jul 24, 2025
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est --

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

RHO6.SG

5.55%

MSCI WORLD (^990100-USD-STRD)

0.19%

1-Year Return

RHO6.SG

25.39%

MSCI WORLD (^990100-USD-STRD)

9.31%

3-Year Return

RHO6.SG

7.12%

MSCI WORLD (^990100-USD-STRD)

0.00%

5-Year Return

RHO6.SG

1.12%

MSCI WORLD (^990100-USD-STRD)

80.01%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Roche Holding AG

33.94

-1.73%

Mkt Cap EUR -

Industry Drug Manufacturers—General

96.99

-0.47%

Mkt Cap EUR -

Industry Drug Manufacturers—General

96.80

-1.43%

Mkt Cap EUR -

Industry Drug Manufacturers—General

97.06

-0.92%

Mkt Cap EUR -

Industry Drug Manufacturers—General

Johnson & Johnson

137.84

+0.38%

Mkt Cap EUR 331.653B

Industry Drug Manufacturers—General

19.98

-1.52%

Mkt Cap EUR 113.571B

Industry Drug Manufacturers—General

MIRA Pharmaceuticals, Inc.

1.2200

-2.40%

Mkt Cap 20.513M

Industry Drug Manufacturers—General

90.91

-0.22%

Mkt Cap CHF 179.555B

Industry Drug Manufacturers—General

Novo Nordisk A/S

59.25

+2.51%

Mkt Cap EUR 264.651B

Industry Drug Manufacturers—General

118.17

-0.19%

Mkt Cap 17.315B

Industry Drug Manufacturers—General

Valuation Measures

    Annual 

As of 5/9/2025

Market Cap

221.71B
Enterprise Value

242.10B
Trailing P/E

24.59
Forward P/E

12.47
PEG Ratio (5yr expected)

0.63
Price/Sales (ttm)

3.26
Price/Book (mrq)

6.35
Enterprise Value/Revenue

3.62
Enterprise Value/EBITDA

13.60

Financial Highlights

Profitability and Income Statement

Profit Margin

--
Return on Assets (ttm)

--
Return on Equity (ttm)

--
Revenue (ttm)

--
Net Income Avi to Common (ttm)

--
Diluted EPS (ttm)

--

Balance Sheet and Cash Flow

Total Cash (mrq)

--
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

--

NOTA.F Novartis AG

96.00

-1.23%

RHO6.BE Roche Holding AG

34.30

-1.44%

NOTA.DU Novartis AG

96.80

-1.43%

NOV.DE Novo Nordisk A/S

59.25

+2.51%

ZEG.DE AstraZeneca PLC

121.10

+0.83%

NOTA.BE Novartis AG

97.80

-0.61%

SNW.HM Sanofi SA

92.74

+0.56%

SANO.VI Sanofi

92.88

+0.88%

GS71.DE GSK plc

16.34

+0.71%

RHO6.F Roche Holding AG

34.64

-2.41%

NOVNEE.SW Novartis AG

90.88

-0.50%

AMG.DE Amgen Inc.

239.90

-0.58%

SNW.DE Sanofi

92.73

+0.90%

NOTA.SG Novartis AG

97.40

+0.21%

MRK.VI Merck & Co., Inc.

69.00

+0.15%

LLY.F Eli Lilly and Company

662.30

+0.75%